Counterattacks of the 2nd line drug in Rheumatoid Arthritis drugs… all efforts on market penetration

Published: 2013-12-09 06:59:00
Updated: 2013-12-09 06:59:00
Reimbursement extended of Orencia and Acktemla as primary drug … competing with Humira.
(Yakup Shinmoon)

The 2nd line drug of rheumatoid arthritis extended insurance reimbursement coverage as the 1st drug. Therefore, the first and second line drugs are going to compete.

According to pharma...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.